AI assistant
Sending…
Minerva Neurosciences, Inc. — Director's Dealing 2017
Sep 5, 2017
35086_dirs_2017-09-05_8c7c1f64-3b0c-44dc-b215-f6f28f5d11b4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2017-09-01
Reporting Person: Saoud Jay (SVP and Head of R&D)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-01 | Employee Stock Option (Right to Buy) | $6.45 | A | 100000 | Acquired | 2017-08-31 | Common Stock (100000) | Direct |
Footnotes
F1: This option vested as to 25% of the shares on September 1, 2018 and then in quarterly installments over 3 years thereafter.
More from Minerva Neurosciences, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 27
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17